← Back to headlines
Jim Cramer Discusses Various Stock Market Insights and Company Valuations
Jim Cramer has offered diverse insights on the stock market, including his reluctance to recommend Pfizer despite its dividend, defending a struggling tech giant, and highlighting future earnings projections for Oracle and Meta's entry into the neocloud business.
9 Jul, 15:52 — 9 Jul, 16:25
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left2
Left (2)
Yahoocnbc
Center
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual8d ago
Cramer defends a struggling tech giant and says another stock could soon be a buy
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Read full article →YahooMostly Factual8d ago
‘It Kills Me to Say That’: Cramer Won’t Recommend Pfizer, Even With Its 7% Dividend
Read full article →Coverage Timeline
First report: cnbc · 9 Jul, 15:52|Full coverage: 2 · 34m|Window: 34m
Left-leaningCenterRight-leaning
